BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 10 Apr · 18:00 IST

Biocon Limited has informed the Exchange regarding 'Certificate pursuant to SEBI Master Circular no. SEBI/HO/DDHS/PoD1/P/CIR/2024/54dated May 22, 2024.'.

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has filed a certificate with the stock exchanges as required under the SEBI Master Circular (SEBI/HO/DDHS/PoD1/P/CIR/2024/54) dated May 22, 2024. This circular governs disclosure and compliance norms for entities that have listed their debt securities (such as non-convertible debentures) on the exchanges. The filing is a routine regulatory submission confirming the company's adherence to ongoing obligations related to its listed debt instruments, covering matters like asset coverage, financial covenants, and other disclosures.

Likely market impact

This is a routine compliance filing with no material impact on shareholders or the stock price. It simply fulfils a recurring regulatory requirement linked to Biocon's listed debt securities.